What is CCLD (CCLD) stock price today?

CCLD (CCLD) is currently trading at $2.28, down 3.19% today.

What is CCLD P/E ratio?

CCLD's P/E ratio is 22.80. This is near the market average.

What is CCLD return on equity (ROE)?

CCLD's return on equity (ROE) is 18.33%, indicating how efficiently the company generates profit from shareholders' equity. This is above the market average.

What is CCLD's market cap?

CCLD has a market capitalization of $96.67M.

NASDAQ · Medical - Healthcare Information Services

CCLD (CCLD) Stock

$2.28 -3.19% NASDAQ: CCLD Healthcare

Valuation

Metric	Value
Price	$2.28
Market Cap	$96.67M
P/E Ratio	22.80
P/B Ratio	1.61
P/S Ratio	0.78
EPS (TTM)	$0.00
52-Week High	$4.01
52-Week Low	$2.08
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	18.33%
ROA	12.50%
ROCE	18.33%
Gross Margin	9.17%
Operating Margin	9.17%
Net Margin	7.87%
Debt/Equity	0.10
Current Ratio	1.08

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$140.0M	$139.0M	$117.0M	$111.0M	$120.0M
Operating Profit	$4.0M	$7.0M	$-47.0M	$9.0M	$11.0M
Net Profit	$3.0M	$5.0M	$-49.0M	$8.0M	$11.0M
EPS	$-0.77	$-0.67	$-4.11	$-0.28	$0.10
Op Margin	2.5%	4.8%	-40.3%	8.2%	9.5%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$141.0M	$136.0M	$78.0M	$72.0M	$88.0M
Total Liabilities	$43.0M	$34.0M	$36.0M	$22.0M	$28.0M
Cash	$9.0M	$12.0M	$3.0M	$5.0M	$3.0M
Borrowings	$17.0M	$14.0M	$15.0M	$3.0M	$4.0M

Latest News

Empower, a CareCloud Company, Helps Wound-Care Provider Reverse More Than $1 Million in Alleged Overpayments GlobeNewswire · Jun 8, 2026 Sector Update: Healthcare Stocks Higher Late Afternoon MT Newswires · Jun 5, 2026 CareCloud Shareholders Approve Board Re-Elections, Executive Compensation at Annual Meeting MT Newswires · Jun 5, 2026 CareCloud Shareholders Overwhelmingly Approve All Proposals, Reaffirming Confidence in Company Leadership and Strategy GlobeNewswire · Jun 5, 2026 CareCloud Acquires Empower Healthcare & Compliance Partners, adding a High-Growth Compliance Business to its AI-powered Platform GlobeNewswire · May 26, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$13.0M	$21.0M	$15.0M	$21.0M	$29.0M
Investing Cash Flow	$-34.0M	$-24.0M	$-23.0M	$-9.0M	$-29.0M
Financing Cash Flow	$-2.0M	$-2.0M	$-2.0M	$-1.0M	$0
Net Cash Flow	$-11.0M	$2.0M	$-9.0M	$2.0M	$-2.0M
Free Cash Flow	$3.0M	$9.0M	$4.0M	$19.0M	$24.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	3.50
FCF Yield	28.15%
Quick Ratio	1.09
Interest Coverage	—
Return 1Y	1.30%
Return 3Y	-19.86%
Return 5Y	-69.21%

Ownership

Insiders Held15.12%

Institutions Held28.91%

Institutions Float Held34.06%

Institutional Holder	Shares	Report Date
Vanguard Capital Management LLC	1,473,701	2026-03-31
Hillsdale Investment Management Inc.	804,508	2026-03-31
American Century Companies Inc	739,570	2026-03-31
Essex Investment Management Co LLC	697,836	2026-03-31
Ameriprise Financial, Inc.	683,513	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AGEN	$7.99	+4.99%	3.04	$332.72M	0.00%
APYX	$3.05	+0.00%	-17.90	$128.44M	0.00%
HURA	$2.03	-4.69%	-3.75	$129.28M	0.00%
IRD	$3.83	+5.80%	-2.99	$316.23M	0.00%
JYNT	$8.36	-0.95%	45.89	$119.18M	0.00%

About CCLD

CCLD is led by CEO Stephen A. Snyder, publicly traded since 2014.

CCLD stock trades at $2.28 with a market capitalization of $96.67M. The stock is valued at a price-to-earnings (P/E) ratio of 22.80, price-to-book of 1.61, price-to-sales of 0.78. Over the past 52 weeks the stock has ranged between $2.08 and $4.01, and currently trades 43.1% below its 52-week high.

On profitability, CCLD generates a return on equity (ROE) of 18.33%, above the typical market average, return on capital employed of 18.33%, an operating margin of 9.17%, a net profit margin of 7.87%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides